Cor Vasa 2019, 61(3):e300-e304 | DOI: 10.33678/cor.2019.028

Depression, cardiovascular disease, and related pathophysiologic mechanisms in women

Tea Gegenavaa,b, Maka Gegenavab,c
a Leiden University Medical Center, Department of Cardiology, Leiden, Netherlands
b Tbilisi State Medical University, Department of Internal Medicine, Tbilisi, Georgia
c Leiden University Medical Center, Department of Rheumatology, Leiden, Netherlands

Background: Although depression is already elevated to the status of a risk factor for CVD in AHA and EACPR guidelines and recommendations, there is lack of gender specific information. Studies have proven that depression can be more prevalent in women at specific age and more significantly predisposes cardiovascular mortality compared to men. Purpose: The goal of our manuscript was to review current evidences suggesting prevalence of cardiovascular disease and depression in women, to find out the link between depression and cardiovascular disease in this particular population and determine plausible biological mechanism to account for this relationship.

Methods: We reviewed original manuscripts and meta-analysis published before Apr 20, 2019.

Results: Our review identified consistent association between depression and cardiovascular disease in women and predictive value of depression on cardiovascular mortality, also there are underlined some plausible pathophysiologic mechanisms responsible for this relation especially in women.

Conclusions: Women are more frequently experiencing lack of social support and social integration, as well as presence of depression leading to adverse CVD outcome and enhanced risk of cardiac death, early assess- ment of psychosocial risk factors even in low CVD risk female patients will be paramount to avoid future complication and define effective timing for cognitive-based intervention.

Keywords: Cardiovascular mortality in women, Depression

Received: April 26, 2019; Accepted: May 28, 2019; Published: June 21, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Gegenava T, Gegenava M. Depression, cardiovascular disease, and related pathophysiologic mechanisms in women. Cor Vasa. 2019;61(3):e300-304. doi: 10.33678/cor.2019.028.
Download citation

References

  1. Benjamin EJ, Muntner P, Alonso A, et al. Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation 2019;139:e56-e528. Go to original source... Go to PubMed...
  2. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation 2011;123:e18-e209. Go to original source... Go to PubMed...
  3. Thompson DR, Ski CF. Psychosocial interventions in cardiovascular disease--what are they? Eur J Prev Cardiol 2013;20:916-917. Go to original source... Go to PubMed...
  4. Linden W, Stossel C, Maurice J. Psychosocial interventions for patients with coronary artery disease: a meta-analysis. Arch Intern Med 1996;156:745-752. Go to original source...
  5. Piepoli MF, Hoes AW, Agewall S, et al. [2016 European guidelines on cardiovascular disease prevention in clinical practice. The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts. Developed with the special contribution of the European Association for CardiovascularPrevention & Rehabilitation]. G Ital Cardiol 2017;18:547-612. Go to PubMed...
  6. Lichtman JH, Froelicher ES, Blumenthal JA, et al. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association. Circulation 2014;129:1350-1369. Go to original source... Go to PubMed...
  7. Fiedorowicz JG. Depression and cardiovascular disease: an update on how course of illness may influence risk. Curr Psychiatry Rep 2014;16:492. Go to original source... Go to PubMed...
  8. Kessler RC, McGonagle KA, Nelson CB, et al. Sex and depression in the National Comorbidity Survey. II: Cohort effects. J Affect Disord 1994;30:15-26. Go to original source... Go to PubMed...
  9. Kornstein SG, Sloan DM, Thase ME. Gender-specific differences in depression and treatment response. Psychopharmacol Bull 2002;36:99-112. Go to PubMed...
  10. Parashar S, Rumsfeld JS, Reid KJ, et al. Impact of depression on sex differences in outcome after myocardial infarction. Circ Cardiovasc Qual Outcomes 2009;2:33-40. Go to original source... Go to PubMed...
  11. Anderson RJ, Freedland KE, Clouse RE, et al. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001;24:1069-1078. Go to original source... Go to PubMed...
  12. Clouse RE, Lustman PJ, Freedland KE, et al. Depression and coronary heart disease in women with diabetes. Psychosom Med 2003;65:376-383. Go to original source... Go to PubMed...
  13. Shively CA, Laber-Laird K, Anton RF. Behavior and physiology of social stress and depression in female cynomolgus monkeys. Biol Psychiatry 1997;41:871-882. Go to original source... Go to PubMed...
  14. Brown GW. Life events and affective disorder: replications and limitations. Psychosom Med 1993;55:248-259. Go to original source... Go to PubMed...
  15. Brown GW, Harris TO, Eales MJ. Aetiology of anxiety and depressive disorders in an inner-city population. 2. Comorbidity and adversity. Psychol Med 1993;23:155-165. Go to original source... Go to PubMed...
  16. Stetler C, Miller GE. Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research. Psychosom Med 2011;73:114-126. Go to original source... Go to PubMed...
  17. Dutta P, Courties G, Wei Y, et al. Myocardial infarction accelerates atherosclerosis. Nature 2012;487:325-329. Go to original source... Go to PubMed...
  18. Straub RH, Buttgereit F, Cutolo M. Alterations of the hypothalamic-pituitary-adrenal axis in systemic immune diseases - a role for misguided energy regulation. Clin Experiment Rheumatol 2011;29:S23-S31.
  19. Munkholm K, Braüner JV, Kessing LV, Vinberg M. Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis. J Psychiatr Res 2013;47:1119-1133. Go to original source... Go to PubMed...
  20. Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 2009;71:171-186. Go to original source... Go to PubMed...
  21. Gegenava T, Gegenava M, Kavtaradze G. C-reactive protein level correlation with depression and anxiety among patients with coronary artery disease. Georgian Med News 2011;(194):34-37.
  22. Rabe-Jabłońska J, Poprawska I. Levels of serum total cholesterol and LDL-cholesterol in patients with major depression in acute period and remission. Med Sci Monit 2000;6:539-547. Go to PubMed...
  23. Rozzini R, Bertozzi B, Barbisoni P, et al. Low serum cholesterol and serotonin metabolism. Risk of depression is higher in elderly patients with lowest serum cholesterol values. BMJ 1996;312:1298-1299; author reply 1299. Go to original source... Go to PubMed...
  24. Gegenava M, Kavtaradze G. Risk factors for coronary heart disease in patients with schizophrenia. Georgian Med News 2006;(134):55-58.
  25. Gegenava T, Gegenava M, Kavtaradze G, Gvetadze L. Depression, anxiety and cholesterol level in the pre- and postoperative periods of the coronary angioplasty and aorto-coronary bypass graft surgery. Georg Med News 2008;(158):25-28.
  26. LaRosa JC. Lipids and cardiovascular disease: do the findings and therapy apply equally to men and women? Womens Health Issues 1992;2:102-111; discussion 111-103. Go to original source... Go to PubMed...
  27. Ancelin ML, Carrière I, Boulenger JP, et al. Gender and genotype modulation of the association between lipid levels and depressive symptomatology in community-dwelling elderly (the ESPRIT study). Biol Psychiatry 2010;68:125-132. Go to original source... Go to PubMed...
  28. Wysokinski A, Strzelecki D, Kloszewska I. Levels of triglycerides, cholesterol, LDL, HDL and glucose in patients with schizophrenia, unipolar depression and bipolar disorder. Diabetes Metab Syndr 2015;9:168-176. Go to original source... Go to PubMed...
  29. Kim EY, Kim SH, Ha K, et al. Depression trajectories and the association with metabolic adversities among the middle-aged adults. J Affect Disord 2015;188:14-21. Go to original source... Go to PubMed...
  30. López-León S, Janssens AC, González-Zuloeta Ladd AM, et al. Meta-analyses of genetic studies on major depressive disorder. Mol Psychiatry 2008;13:772-785. Go to original source... Go to PubMed...
  31. Fischer P, Gruenblatt E, Pietschmann P, et al. Serotonin transporter polymorphism and LDL-cholesterol. Mol Psychiatry 2006;11:707-709. Go to original source... Go to PubMed...
  32. Ryan J, Ancelin ML. Genetic and Epigenetic Regulation of the Serotonin Transporter Gene in Late-Life Depression. J Geriatr Psychiatry Neurol 2019;32:175-177. Go to original source... Go to PubMed...
  33. Kim JM, Stewart R, Kim SW, et al. Cholesterol and serotonin transporter polymorphism interactions in late-life depression. Neurobiol Aging 2011;32:336-343. Go to original source... Go to PubMed...
  34. Kessler RC, McGonagle KA, Swartz M, et al. Sex and depression in the National Comorbidity Survey. I: Lifetime prevalence, chronicity and recurrence. J Affect Disord 1993;29:85-96. Go to original source... Go to PubMed...
  35. Horsten M, Mittleman MA, Wamala SP, et al. Depressive symptoms and lack of social integration in relation to prognosis of CHD in middle-aged women. The Stockholm Female Coronary Risk Study. Eur Heart J 2000;21:1072-1080. Go to original source... Go to PubMed...
  36. Vaccarino V, Johnson BD, Sheps DS, et al. Depression, inflammation, and incident cardiovascular disease in women with suspected coronary ischemia: the National Heart, Lung, and Blood Institute-sponsored WISE study. J Am Coll Cardiol 2007;50:2044-2050. Go to original source... Go to PubMed...
  37. Wagner JA, Tennen H, Finan PH, et al. Lifetime history of depression, type 2 diabetes, and endothelial reactivity to acute stress in postmenopausal women. Int J Behav Med 2012;19:503-511. Go to original source... Go to PubMed...
  38. Rapp MA, Rieckmann N, Lessman DA, et al. Persistent depressive symptoms after acute coronary syndrome are associated with compromised white matter integrity in the anterior cingulate: a pilot study. Psychother Psychosom 2010;79:149-155. Go to original source... Go to PubMed...
  39. Carney RM, Freedland KE, Steinmeyer B, et al. Cardiac Risk Markers and Response to Depression Treatment in Patients With Coronary Heart Disease. Psychosom Med 2016;78:49-59. Go to original source... Go to PubMed...
  40. Drory Y, Kravetz S, Hirschberger G. Long-term mental health of women after a first acute myocardial infarction. Arch Phys Med Rehabil 2003;84:1492-1498. Go to original source... Go to PubMed...
  41. Stern MJ, Pascale L, Ackerman A. Life adjustment postmyocardial infarction: determining predictive variables. Arch Intern Med 1977;137:1680-1685. Go to original source...
  42. Frasure-Smith N, Lesperance F. Recent evidence linking coronary heart disease and depression. Can J Psychiatry 2006;51:730-737. Go to original source... Go to PubMed...
  43. Carney RM, Freedland KE, Smith L, et al. Relation of depression and mortality after myocardial infarction in women. Circulation 1991;84:1876-1877. Go to original source...
  44. Brezinka V, Kittel F. Psychosocial factors of coronary heart disease in women: a review. Soc Sci Med 1996;42:1351-1365. Go to original source... Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.





Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.